European Medical Journal

TAVR Reinterventions on the Rise, Data Shows

TAVR reinterventions are increasing nationwide. Read on to see the latest trends and what it means for aortic valve care.
Business Wire

JenaValve Technology Closes $50 Million Financing

IRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic ...
Medscape

First TAVR for Aortic Regurgitation Moves to Phase 3 Trial

WASHINGTON — A phase 3 randomized trial will soon begin for the first transcatheter aortic valve replacement (TAVR) device for the treatment of aortic valve regurgitation after promising results in a ...
Healio

‘Minimalist approach’ of local anesthesia without sedation safe for many during TAVR

Please provide your email address to receive an email when new articles are posted on . A strategy of local anesthesia without sedation was safe vs. conscious sedation for patients undergoing TAVR.
Hosted on MSN

FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients

The US Food and Drug Administration (FDA) has approved Edwards Lifesciences' SAPIEN 3 transcatheter aortic valve replacement (TAVR) platform for the treatment of patients with asymptomatic severe ...
Medscape

FDA Approves TAVR in Asymptomatic Severe Stenosis

A transcatheter aortic valve replacement (TAVR) therapy was approved by the US Food and Drug Administration (FDA) for patients with severe aortic stenosis even without symptoms. This is the first FDA ...